News
InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem to Participate in Lake Street’s 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem Reports Second Quarter 2023 Financial Results
Record Net Revenues of $31.7 million Representing 17% Growth From the Prior Year ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for...
InfuSystem to Report Second Quarter 2023 Financial Results on August 3, 2023
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Set to Join Russell 3000® Index
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023
Investor Presentation to be held at 9:15 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Reports First Quarter 2023 Financial Results
Record Net Revenues of $30.4 million Representing 13% Growth From the Prior Year ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care...
InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2022
Full Year 2022 vs. Full Year 2021: Record Net Revenues: $109.9 million, a 7% increase ITS Revenue: $68.9 million - DME Revenue: $41.0 million, increases of 5% and 12% Adjusted EBITDA: $20.7 million 2023 Full Year Guidance - Revenue Growth 8% to 10%; Adjusted EBITDA...